{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:10:13Z","timestamp":1778634613779,"version":"3.51.4"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P011535\/1"],"award-info":[{"award-number":["MR\/P011535\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0500717"],"award-info":[{"award-number":["G0500717"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0802782"],"award-info":[{"award-number":["G0802782"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0801807"],"award-info":[{"award-number":["G0801807"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N022556\/1"],"award-info":[{"award-number":["MR\/N022556\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.mce.2021.111196","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T20:19:58Z","timestamp":1612642798000},"page":"111196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Pubertal FGF21 deficit is central in the metabolic pathophysiology of an ovine model of polycystic ovary syndrome"],"prefix":"10.1016","volume":"525","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-7902","authenticated-orcid":false,"given":"Katarzyna J.","family":"Siemienowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaudia","family":"Furmanska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-9354","authenticated-orcid":false,"given":"Panagiotis","family":"Filis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Talia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4522-9672","authenticated-orcid":false,"given":"Jennifer","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mick T.","family":"Rae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Colin","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2021.111196_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049977","article-title":"FGF21 requires \u03b2klotho to act in vivo","volume":"7","author":"Adams","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2021.111196_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmet.2012.08.007","article-title":"The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue","volume":"2","author":"Adams","year":"2012","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.mce.2021.111196_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067160","article-title":"Association between serum atypical fibroblast growth factors 21 and 19 and pediatric nonalcoholic fatty liver disease","volume":"8","author":"Alisi","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2021.111196_bib4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/jgh.13241","article-title":"Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys","volume":"31","author":"Ayonrinde","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2021.111196_bib5","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1210\/en.2009-0532","article-title":"Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis","volume":"150","author":"Badman","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2021.111196_bib6","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1111\/bph.14383","article-title":"A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway","volume":"175","author":"Bao","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mce.2021.111196_bib7","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2018-02414","article-title":"Plasma fibroblast growth factor 21 is associated with severity of nonalcoholic steatohepatitis in patients with obesity and type 2 diabetes","volume":"104","author":"Barb","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111196_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S2040174417001118","article-title":"Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure","volume":"9","author":"Barrett","year":"2018","journal-title":"J. Dev. Orig. Health Dis."},{"key":"10.1016\/j.mce.2021.111196_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.gastro.2016.09.017","article-title":"Estrogen signals through peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 to reduce oxidative damage associated with diet-induced fatty liver disease","volume":"152","author":"Besse-Patin","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2021.111196_bib10","article-title":"Significant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents","volume":"7","author":"Bisgaard","year":"2014","journal-title":"Int. J. Pediatr. Endocrinol."},{"key":"10.1016\/j.mce.2021.111196_bib11","first-page":"13","article-title":"Detrimental and protective fat: body fat distribution and its relation to metabolic disease","volume":"17","author":"Booth","year":"2014","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"key":"10.1016\/j.mce.2021.111196_bib12","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2014.05.032","article-title":"Insulin resistance and its relationship with high molecule weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history","volume":"102","author":"Cankaya","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2021.111196_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111280","article-title":"The local effects of ovarian diathermy in an ovine model of polycystic ovary syndrome","volume":"9","author":"Connolly","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2021.111196_bib14","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2021.111196_bib15","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2337\/db20-0209","article-title":"The effects of B1344, a novel fibroblast growth factor 21 analog, on nonalcoholic steatohepatitis in nonhuman primates","volume":"69","author":"Cui","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2021.111196_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.fertnstert.2016.09.042","article-title":"Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome","volume":"107","author":"Daan","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2021.111196_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cmet.2012.08.002","article-title":"\u03b2Klotho is required for fibroblast growth factor 21 effects on growth and metabolism","volume":"16","author":"Ding","year":"2012","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2021.111196_bib18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2021.111196_bib19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast growth factor-21 regulates PPAR\u03b3 activity and the antidiabetic actions of thiazolidinediones","volume":"148","author":"Dutchak","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.mce.2021.111196_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.steroids.2017.12.009","article-title":"Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome","volume":"130","author":"Echibur\u00fa","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2021.111196_bib21","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/humrep\/del146","article-title":"Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study","volume":"21","author":"Escobar-Morreale","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2021.111196_bib22","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2337\/db08-1571","article-title":"Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression","volume":"58","author":"Estall","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2021.111196_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/humrep\/der396","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"27","author":"Fauser","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2021.111196_bib24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease","volume":"65","author":"Fazel","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.mce.2021.111196_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.mce.2021.111196_bib26","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2021.111196_bib27","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2014.07.044","article-title":"Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets","volume":"147","author":"Fisher","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2021.111196_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2021.111196_bib29","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2016.01.025","article-title":"Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe?","volume":"150","author":"Gao","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2021.111196_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3109\/09513590.2010.487587","article-title":"Serum fibroblast growth factor 21 levels in polycystic ovary syndrome","volume":"26","author":"Gorar","year":"2010","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.mce.2021.111196_bib31","doi-asserted-by":"crossref","first-page":"10275","DOI":"10.1038\/srep10275","article-title":"Serum FGF21 levels are associated with brown adipose tissue activity in humans","volume":"5","author":"Hanssen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2021.111196_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024877","article-title":"The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep","volume":"6","author":"Hogg","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2021.111196_bib33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/en.2011-1607","article-title":"Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome","volume":"153","author":"Hogg","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2021.111196_bib34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2021.111196_bib35","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/archinternmed.2011.288","article-title":"Polycystic ovary syndrome in the United States: clinical visit rates, characteristics, and associated health care costs","volume":"171","author":"Jason","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.mce.2021.111196_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.15252\/emmm.201708791","article-title":"FGF21 gene therapy as treatment for obesity and insulin resistance","volume":"10","author":"Jimenez","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mce.2021.111196_bib37","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1530\/EC-20-0152","article-title":"FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation","volume":"9","author":"Keinicke","year":"2020","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.mce.2021.111196_bib38","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2021.111196_bib39","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2006-1168","article-title":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21","volume":"148","author":"Kharitonenkov","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2021.111196_bib40","first-page":"4750","article-title":"An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function","volume":"8","author":"Lee","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.mce.2021.111196_bib41","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1371\/journal.pbio.0030101","article-title":"PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis","volume":"3","author":"Leone","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.mce.2021.111196_bib42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2020.01.004","article-title":"PGC-1\u03b1 isoforms coordinate to balance hepatic metabolism and apoptosis in inflammatory environments","volume":"34","author":"L\u00e9veill\u00e9","year":"2020","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.mce.2021.111196_bib43","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tem.2019.05.007","article-title":"Going back to the biology of FGF21: new insights","volume":"30","author":"Lewis","year":"2019","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.mce.2021.111196_bib44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.diabet.2016.12.003","article-title":"FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: the BCAMS Study","volume":"43","author":"Li","year":"2017","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.mce.2021.111196_bib45","article-title":"Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mce.2021.111196_bib46","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3945\/ajcn.112.046417","article-title":"A common variant in the peroxisome proliferator-activated receptor-\u03b3 coactivator-1\u03b1 gene is associated with nonalcoholic fatty liver disease in obese children","volume":"97","author":"Lin","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.mce.2021.111196_bib47","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","article-title":"Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice","volume":"17","author":"Lin","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2021.111196_bib48","first-page":"1011","article-title":"Lack of fibroblast growth factor 21 accelerates metabolic liver injury characterized by steatohepatities in mice","volume":"6","author":"Liu","year":"2016","journal-title":"Am. J. Canc. Res."},{"key":"10.1016\/j.mce.2021.111196_bib49","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.mce.2021.111196_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejogrb.2011.12.012","article-title":"Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women","volume":"161","author":"Maliqueo","year":"2012","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.mce.2021.111196_bib51","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1210\/jc.2010-1290","article-title":"Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance","volume":"96","author":"Manneras-Holm","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111196_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tem.2014.12.003","article-title":"Metabolic risk in PCOS: phenotype and adiposity impact","volume":"26","author":"Moran","year":"2015","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.mce.2021.111196_bib53","doi-asserted-by":"crossref","first-page":"G979","DOI":"10.1152\/ajpgi.00169.2012","article-title":"PGC-1\u03b1 overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion","volume":"303","author":"Morris","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.mce.2021.111196_bib54","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.3389\/fimmu.2019.02893","article-title":"Macrophage function in the pathogenesis of non-alcoholic fatty liver disease: the Mac Attack","volume":"10","author":"Oates","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mce.2021.111196_bib55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2012.10.005","article-title":"Sheep models of polycystic ovary syndrome phenotype","volume":"373","author":"Padmanabhan","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2021.111196_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-019-02085-7","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"67","author":"Paschou","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.mce.2021.111196_bib57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41575-018-0089-3","article-title":"Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators","volume":"16","author":"Piccinin","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2021.111196_bib58","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1\u03b1 and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response","volume":"106","author":"Potthoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.mce.2021.111196_bib59","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1210\/jc.2005-1002","article-title":"Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance","volume":"90","author":"Puder","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111196_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056263","article-title":"The pancreas is altered by in utero androgen exposure: implications for clinical conditions such as polycystic ovary syndrome (PCOS)","volume":"8","author":"Rae","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2021.111196_bib61","doi-asserted-by":"crossref","first-page":"27408","DOI":"10.1038\/srep27408","article-title":"Developmental programming of polycystic ovary syndrome (PCOS): prenatal androgens establish pancreatic islet \u03b1\/\u03b2 cell ratio and subsequent insulin secretion","volume":"6","author":"Ramaswamy","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2021.111196_bib62","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","article-title":"Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome","volume":"25","author":"Risal","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2021.111196_bib63","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/00365513.2014.900821","article-title":"Fibroblast growth factor 21 and its relation to metabolic parameters in women with polycystic ovary syndrome","volume":"74","author":"Sahin","year":"2014","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.mce.2021.111196_bib64","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/S0140-6736(18)31785-9","article-title":"Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"392","author":"Sanyal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2021.111196_bib65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/liv.14279","article-title":"Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis","volume":"40","author":"Sarkar","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.mce.2021.111196_bib66","doi-asserted-by":"crossref","first-page":"20195","DOI":"10.1038\/s41598-019-56790-4","article-title":"Fetal androgen exposure is a determinant of adult male metabolic health","volume":"9","author":"Siemienowicz","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2021.111196_bib67","article-title":"Insights into manipulating postprandial energy expenditure to manage weight gain in polycystic ovary syndrome (PCOS)","volume":"101164","author":"Siemienowicz","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.mce.2021.111196_bib68","doi-asserted-by":"crossref","first-page":"111042","DOI":"10.1016\/j.mce.2020.111042","article-title":"Aberrant subcutaneous adipogenesis precedes adult metabolic dysfunction in an ovine model of polycystic ovary syndrome (PCOS)","volume":"519","author":"Siemienowicz","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2021.111196_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.80","article-title":"Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice","volume":"6","author":"So","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mce.2021.111196_bib70","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","article-title":"A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2021.111196_bib71","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.bbadis.2015.02.012","article-title":"Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet","volume":"1852","author":"Tanaka","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2021.111196_bib72","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med."},{"key":"10.1016\/j.mce.2021.111196_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040164","article-title":"FGF21 promotes metabolic homeostasis via white adipose and leptin in mice","volume":"7","author":"V\u00e9niant","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2021.111196_bib74","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects","volume":"56","author":"Westerbacka","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2021.111196_bib75","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2021.111196_bib76","doi-asserted-by":"crossref","first-page":"E1105","DOI":"10.1152\/ajpendo.00348.2009","article-title":"Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects","volume":"297","author":"Xu","year":"2009","journal-title":"Am. J. Physiol. Endocrinol."},{"key":"10.1016\/j.mce.2021.111196_bib77","article-title":"Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB","volume":"7","author":"Yang","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2021.111196_bib78","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.27060","article-title":"Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1\u03b1-mediated antioxidant capacity in mice","volume":"60","author":"Ye","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2021.111196_bib79","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0015-0282(03)00265-6","article-title":"Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome","volume":"79","author":"Yildirim","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2021.111196_bib80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-230X-8-27","article-title":"Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD)","volume":"8","author":"Yoneda","year":"2008","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.mce.2021.111196_bib81","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tips.2019.12.005","article-title":"Targeting FGF21 for the treatment of nonalcoholic steatohepatitis","volume":"41","author":"Zarei","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mce.2021.111196_bib82","doi-asserted-by":"crossref","first-page":"9923","DOI":"10.7150\/thno.45988","article-title":"Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling","volume":"10","author":"Zheng","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.mce.2021.111196_bib83","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/abbs\/gmu097","article-title":"FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway","volume":"46","author":"Zhu","year":"2014","journal-title":"Acta Biochim. Biophys. Sin."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030372072100040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030372072100040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:15:05Z","timestamp":1778631305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030372072100040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":83,"alternative-id":["S030372072100040X"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2021.111196","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pubertal FGF21 deficit is central in the metabolic pathophysiology of an ovine model of polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2021.111196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111196"}}